Sindrom defitsita vnimaniya i giperaktivnosti: sovremennye podkhody k diagnostike i farmakoterapii


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Attention deficit hyperactivity disorder (ADHD) previously was considered as a disease of children and adolescents, but studies have shown that symptoms undergo a transformation and continue to be found in adulthood approximately in 50 % of patients. The article discusses the changes in the ADHD diagnostic criteria according to the DSM-V classification, where for the first time the threshold number of ADHD symptoms for adults is presented, and age dynamics of its manifestations is reflected. Treatment for ADHD should be prolonged enough and planned on the basis of assessment of the main ADHD symptoms and comorbid disorders manifestations. When selecting pharmacotherapy, drugs, which, when administered as monotherapy, may have a positive effect both on the ADHD manifestations and comorbid disorders should be preferred. The potentials for the use of atomoxetine hydrochloride, hopantenic acid, and some other neuroprotective drugs in ADHD are considered.

Full Text

Restricted Access

About the authors

N. N Zavadenko

Email: zavadenko@mail.ru

References

  1. Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-V). American Psychiatric Association. Washington, 2013.947 p.
  2. Заваденко Н.Н., Симашкова Н.В. Новые подходы к диагностике синдрома дефицита внимания и гиперактивности. Журн. неврол. психиатр. им. С.С. Корсакова. 2014;114(1, вып. 2):45-51.
  3. МКБ-10 - Международная классификация болезней (10-й пересмотр). Классификация психических и поведенческих расстройств. Исследовательские диагностические критерии. СПб., 1994. 208 с.
  4. Diagnostic and Statistical Manual of Mental Disorders, 4th edition (Revision). American Psychiatric Association. Washington, 2000. 943 p.
  5. Goldstein S., Schwebach A.J. The comorbidity of Pervasive Developmental Disorder and Attention Deficit Hyperactvity Disorder: results of a retrospective chart review. J. Autism Dev. Disord. 2004;34(3):329-39.
  6. Lee D.O., Ousley O.Y. Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders. J. Child. Adolesc. Psychopharmacol. 2006;16:737-46.
  7. Симашкова Н.В. Расстройства аутистического спектра. Научно-практическое руководство. М.: Авторская Академия, 2013. 264 с.
  8. Banaschewski T., Poustka L., Holtmann M. Autism and ADHD across the life span: differential diagnoses or comorbidity? Nervenarzt. 2011:82(5):573-81.
  9. Kotte A., Joshi G., Fried R., et al. Autistic traits in children with and without ADHD. Pediatrics. 2013;132(3):612-22.
  10. Barkley R.A. Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment (3rd ed.). New York: Guilford Press, 2005. 770 p.
  11. Баркли Р.А. Дети с вызывающим поведением. Клиническое руководство по обследованию ребенка и тренингу родителей. Пер. с англ. М., 2011. 272 с.
  12. Заваденко Н.Н. Гиперактивность и дефицит внимания в детском возрасте. М., 2005.256 с.
  13. Milberger S., Biederman J., Faraone S.V., Murphy J., Tsuang M.T. Attention deficit hyperactivity disorder and comorbid disorders: issues overlapping symptoms. Am. J. Psychiatry. 1995;152:1793-99.
  14. Jarrett M.A., Ollendick T.H. A conceptual review of the comorbidity of attention-deficit/hyper-activity disorder and anxiety: Implications for future research and practice. Clin. Psychol. Rev. 2008;28:1266-80.
  15. Tannock R. Attention-deficit/ hyperactivity disorder with anxiety disorders. In T.E Brown (Eds.), Attention-deficit disorders and comorbidities in children, adolescents, and adults. Washington, DC: American Psychiatric Press, 2000:125-70.
  16. Чутко Л.С., Айбеков К.А., Лапшина О.В. и др. Коморбидные тревожные расстройства при синдроме дефицита внимания с гиперактивностью. Журн. неврол. психиатр. им. С.С. Корсакова. 2008;108(3):49-52.
  17. Vloet T.D., Konrad K., Herpertz-Dahlmann B., Polier G.G., Gunther T. Impact of anxiety disorders on attentional functions in children with ADHD. J. Affect. Disord. 2010;124(3):283-90.
  18. Genizi J., Gordon S., Kerem N.C., et al. Primary headaches, attention deficit disorder and learning disabilities in children and adolescents. J. Headache Pain. 2013;14:54.
  19. Mazzone L., Vitiello B., Incorpora G., Mazzone D. Behavioral and temperamental characteristics of children and adolescents suffering from primary headache. Cephalalgia. 2006; 26(2):194-201.
  20. Riva D., Usilla A., Aggio F. Attention in children and adolescents with headache. Headache. 2012;52:374-84.
  21. Altin M., El-Shafei A.A., Yu M., et al. Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries. Drugs Context. 2013, 212260, P. 1-12. doi: 10.7573/dic.212260.
  22. Riley A.W., Forrest C.B., Starfield B., et al. The Parent Report Form of the CHIP-Child Edition: reliability and validity. Med. Care. 2004;42:210-20.
  23. Заваденко Н.Н., Суворинова Н.Ю. Синдром дефицита внимания с гиперактивностью: выбор оптимальной продолжительности лекарственной терапии. Журн. неврол. психиатр. им. С.С. Корсакова. 2011;111(10):28-32.
  24. Geller D., Donnelly C., Lopez F., et al. Atomoxetine treatment for pediatric patients with ADHD and comorbid anxiety. J. Am. Acad. Child. Adolesc. Psychiatry. 2007; 46(9):1119-27.
  25. Заваденко Н.Н., Соломасова А.А. Синдром дефицита внимания с гиперактивностью в сочетании с тревожными расстройствами: возможности фармакотерапии. Журн. неврол. психиатр. им. С.С. Корсакова. 2012;112(8):44-8.
  26. Spence S.H., Barrett P.M., Turner C.M. Psychometric properties of the Spence Children's Anxiety Scale with young adolescents. J. Anxiety Disorders. 2003;17(6):605-25.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies